Ibritumomab Intravenous and Lotensin HCT
Determining the interaction of Ibritumomab Intravenous and Lotensin HCT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: benazepril / hydrochlorothiazide
Brand name: Lotensin HCT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Loteprednol
- Ibritumomab Intravenous-Loteprednol and Tobramycin
- Ibritumomab Intravenous-Loteprednol and tobramycin ophthalmic
- Ibritumomab Intravenous-Loteprednol Etabonate
- Ibritumomab Intravenous-Loteprednol Eye Drops
- Ibritumomab Intravenous-Loteprednol Eye Drops 0.2%
- Lotensin HCT-Ibritumomab Tiuxetan
- Lotensin HCT-Ibrutinib
- Lotensin HCT-Ibrutinib Capsules
- Lotensin HCT-Ibrutinib Tablets
- Lotensin HCT-Ibu
- Lotensin HCT-IBU Tablets